Evidence map›Paper›PMID 39657787›Full record

ArticleNucleic acids research2025

Isoleucine-to-valine substitutions support cellular physiology during isoleucine deprivation.

Gautam Kok, Imre F Schene, Eveline F Ilcken, Paula Sobrevals Alcaraz, Marisa I Mendes, Desiree E C Smith, Gajja Salomons, Sawsan Shehata, Judith J M Jans, Reza Maroofian and 6 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Gautam KokDepartment of Metabolic Diseases, Wilhelmina Children's Hospital, University Medical Center Utrecht, Lundlaan 6, 3584 EA Utrecht, The Netherlands.ORCID 0000-0002-4285-3381
Imre F ScheneDepartment of Metabolic Diseases, Wilhelmina Children's Hospital, University Medical Center Utrecht, Lundlaan 6, 3584 EA Utrecht, The Netherlands.
Eveline F IlckenDepartment of Metabolic Diseases, Wilhelmina Children's Hospital, University Medical Center Utrecht, Lundlaan 6, 3584 EA Utrecht, The Netherlands.
Paula Sobrevals AlcarazCenter for Molecular Medicine, University Medical Center Utrecht, Oncode Institute, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.
Marisa I MendesLaboratory Genetic Metabolic Diseases, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.ORCID 0000-0002-6617-3698
Desiree E C SmithLaboratory Genetic Metabolic Diseases, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Gajja SalomonsLaboratory Genetic Metabolic Diseases, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Sawsan ShehataDepartment of Metabolic Diseases, Wilhelmina Children's Hospital, University Medical Center Utrecht, Lundlaan 6, 3584 EA Utrecht, The Netherlands.
Judith J M JansLaboratory of Metabolic Diseases, University Medical Center Utrecht, Lundlaan 6, 3584 EA Utrecht, The Netherlands.
Reza MaroofianDepartment of Neuromuscular Disorders, UCL Queen Square Institute of Neurology, Queen Square, London WC1N 3BG, United Kingdom.
Tim A HoekHubrecht Institute, Royal Netherlands Academy of Arts and Sciences, Uppsalalaan 8, 3584 CT Utrecht, The Netherlands.
Robert M van EsCenter for Molecular Medicine, University Medical Center Utrecht, Oncode Institute, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.ORCID 0000-0002-8299-3813
Holger RehmannDepartment Energy and Biotechnology, Flensburg University of Applied Sciences, Kanzleistraße 91-93 24943 Flensburg, Germany.
Edward E S NieuwenhuisDepartment of Metabolic Diseases, Wilhelmina Children's Hospital, University Medical Center Utrecht, Lundlaan 6, 3584 EA Utrecht, The Netherlands.
Harmjan R VosCenter for Molecular Medicine, University Medical Center Utrecht, Oncode Institute, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.ORCID 0000-0002-4696-6068
Sabine A FuchsDepartment of Metabolic Diseases, Wilhelmina Children's Hospital, University Medical Center Utrecht, Lundlaan 6, 3584 EA Utrecht, The Netherlands.ORCID 0000-0001-9147-2406

Funding

Nederlandse Organisatie voor Wetenschappelijk Onderzoek 184.034.019Netherlands Organization for Health Research and Development 116002008Stichting Metakids
6 · The paper itself

Abstract

Aminoacyl-tRNA synthetases (ARSs) couple tRNAs with their corresponding amino acids. While ARSs can bind structurally similar amino acids, extreme specificity is ensured by subsequent editing activity. Yet, we found that upon isoleucine (I) restriction, healthy fibroblasts consistently incorporated valine (V) into proteins at isoleucine codons, resulting from misacylation of tRNAIle with valine by wildtype IARS1. Using a dual-fluorescent reporter of translation, we found that valine supplementation could fully compensate for isoleucine depletion and restore translation to normal levels in healthy, but not IARS1 deficient cells. Similarly, the antiproliferative effects of isoleucine deprivation could be fully restored by valine supplementation in healthy, but not IARS1 deficient cells. This indicates I > V substitutions help prevent translational termination and maintain cellular function in human primary cells during isoleucine deprivation. We suggest that this is an example of a more general mechanism in mammalian cells to preserve translational speed at the cost of translational fidelity in response to (local) amino acid deficiencies.

Indexed as

Amino Acid SubstitutionIsoleucineProtein BiosynthesisValineAmino Acyl-tRNA SynthetasesCell ProliferationCodonFibroblastsHumansAmino Acyl-tRNA SynthetasesCodonIsoleucineValine

Identifiers

PMID39657787
PMCPMC11724295

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.